United States (US) Mononucleosis Diagnostic Market (2025-2031) | Trends, Segmentation, Companies, Value, Analysis, Competitive Landscape, Size & Revenue, Share, Growth, Industry, Forecast, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Mononucleosis Diagnostic Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Mononucleosis Diagnostic Market - Industry Life Cycle

3.4 United States (US) Mononucleosis Diagnostic Market - Porter's Five Forces

3.5 United States (US) Mononucleosis Diagnostic Market Revenues & Volume Share, By Test Type, 2021 & 2031F

3.6 United States (US) Mononucleosis Diagnostic Market Revenues & Volume Share, By End-User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about mononucleosis and its diagnostic importance

4.2.2 Growing demand for accurate and rapid diagnostic tests

4.2.3 Technological advancements in diagnostic tools and techniques

4.3 Market Restraints

4.3.1 High cost associated with advanced diagnostic tests

4.3.2 Limited availability of specialized diagnostic centers

4.3.3 Stringent regulatory approvals for diagnostic products

6.1 United States (US) Mononucleosis Diagnostic Market, By Test Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Mononucleosis Diagnostic Market Revenues & Volume, By Test Type, 2021- 2031F

6.1.3 United States (US) Mononucleosis Diagnostic Market Revenues & Volume, By Epstein Barr Virus (EBV) Antibody Test, 2021- 2031F

6.1.4 United States (US) Mononucleosis Diagnostic Market Revenues & Volume, By Monospot Test, 2021- 2031F

6.1.5 United States (US) Mononucleosis Diagnostic Market Revenues & Volume, By Complete Blood Count Test, 2021- 2031F

6.2 United States (US) Mononucleosis Diagnostic Market, By End-User

6.2.1 Overview and Analysis

6.2.2 United States (US) Mononucleosis Diagnostic Market Revenues & Volume, By Hospitals, 2021- 2031F

6.2.3 United States (US) Mononucleosis Diagnostic Market Revenues & Volume, By Laboratories, 2021- 2031F

6.2.4 United States (US) Mononucleosis Diagnostic Market Revenues & Volume, By Others, 2021- 2031F

7.1 United States (US) Mononucleosis Diagnostic Market Export to Major Countries

7.2 United States (US) Mononucleosis Diagnostic Market Imports from Major Countries

8.1 Average turnaround time for diagnostic test results

8.2 Adoption rate of new diagnostic technologies

8.3 Number of research studies validating the effectiveness of diagnostic tests

8.4 Percentage of healthcare providers recommending specific diagnostic tests

8.5 Patient satisfaction with the diagnostic process

9.1 United States (US) Mononucleosis Diagnostic Market Opportunity Assessment, By Test Type, 2021 & 2031F

9.2 United States (US) Mononucleosis Diagnostic Market Opportunity Assessment, By End-User, 2021 & 2031F

10.1 United States (US) Mononucleosis Diagnostic Market Revenue Share, By Companies, 2024

10.2 United States (US) Mononucleosis Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters